Study compares immune responses from three major COVID-19 vaccine types

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Fierce Biotech

Moderna's reshaping rolls on with 3 more pipeline purges

With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...
Tennessean

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s ...
Homeland Security Today

Moderna’s COVID-19 Vaccine Records 94.5 Percent Efficacy

The independent, National Institutes of Health (NIH)-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, has informed Moderna Inc. that the trial for its COVID-19 vaccine ...
Investor's Business Daily on MSN

Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10

Shares of ModernaMRNA and other vaccine stocks tumbled Monday after a Food and Drug Administration director suggested Covid ...